Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
BMC Medical Research Methodology|December 13, 2022
Inferences for current chronic graft-versus-host-disease free and relapse free survivalXu Zhang, Scott R Solomon, Connie Sizemore
Advances in Hematology|February 24, 2016
Myeloablative Conditioning with PBSC Grafts for T Cell-Replete Haploidentical Donor Transplantation Using Posttransplant CyclophosphamideScott R Solomon, Melhem Solh, Lawrence E Morris, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 30, 2018
Superior Survival of Black Versus White Patients Following Post-Transplant Cyclophosphamide-Based Haploidentical Transplantation for Adults with Hematologic MalignancyScott R Solomon, Xu Zhang, H Kent Holland, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 28, 2019
Fludarabine and Total-Body Irradiation Conditioning before Ablative Haploidentical Transplantation: Long-Term Safety and EfficacyScott R Solomon, Melhem Solh, Xu Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 28, 2014
Calcineurin inhibitor--free graft-versus-host disease prophylaxis with post-transplantation cyclophosphamide and brief-course sirolimus following reduced-intensity peripheral blood stem cell transplantationScott R Solomon, Melissa Sanacore, Xu Zhang, et al.
Leukemia Research|March 5, 2020
Improved Post remission survival of non- favorable risk Acute Myelogenous Leukemia (AML) patients following initial remission induction therapy with FLAG+/-Idarubicin versus 3 + 7 (Anthracycline + Cytarabine)Melhem M Solh, Scott R Solomon, Lawrence E Morris, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 24, 2018
The Dilemma of Conditioning Intensity: When Does Myeloablative Conditioning Improve Outcomes for Allogeneic Hematopoietic Cell TransplantationMelhem M Solh, Scott R Solomon, Lawrence E Morris, et al.
Bone Marrow Transplantation|April 7, 2019
Fevers post infusion of T-cell replete hla mismatched haploidentical hematopoietic stem cells with post-transplant cyclophosphamide: risk factors and impact on transplant outcomesMelhem M Solh, Elizabeth Dickhaus, Scott R Solomon, et al.
Blood Advances|October 6, 2020
The Transplant Evaluation Rating Scale predicts overall survival after allogeneic hematopoietic stem cell transplantationMelhem M Solh, Dawn Speckhart, Scott R Solomon, et al.
Transplantation and Cellular Therapy|March 29, 2024
Immunosuppression-Free Status at 1 Year after Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation CyclophosphamideMelhem Solh, Asad Bashey, Xu Zhang, et al.
Pageof 8